These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5484526)

  • 1. [Clinical assessment of Cardilan].
    Markiewicz M; Korolko A
    Pol Tyg Lek; 1970 Nov; 25(47):1816-7. PubMed ID: 5484526
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetranicotinoylfructose in disorders of digital blood flow.
    Holti G; Newell DJ; Poole HG
    Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129
    [No Abstract]   [Full Text] [Related]  

  • 3. The action of tetranicotinoylfructose in peripheral vascular disease.
    Andrews G; Judge TG; Walkey F
    Practitioner; 1973 Jul; 211(261):83-5. PubMed ID: 4580277
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arteriosclerosis with permanently administered large doses of nicotinic acid].
    Hermann B; Tornóczky J
    Z Arztl Fortbild (Jena); 1967 Jan; 61(2):77-81. PubMed ID: 5590807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T; Adamczyk R; Dyaczyńska A
    Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of some drugs on platelet aggregation and adhesion.
    Bielawiec M; Perzanowski A; Myśliwiec M
    Acta Univ Carol Med Monogr; 1972; 53():211-4. PubMed ID: 4670729
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of cardilan on blood flow disorders in the extremities].
    Zapalski S; Ciszewski A
    Pol Tyg Lek; 1970 Aug; 25(32):1218-20. PubMed ID: 5472553
    [No Abstract]   [Full Text] [Related]  

  • 9. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
    D'Ayala Valva G
    Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic action of nicergoline in the treatment of cerebrovascular and peripheral disorders].
    Pasotti C; Liverta C; Cacciatori D; Pollini C
    Farmaco Prat; 1974 Sep; 29(9):508-19. PubMed ID: 4608968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress on a new form of treatment of lipoarteriosis].
    Vargas LE; Velasco JR
    Rev Esp Cardiol; 1972; 25(3):239-46. PubMed ID: 5069029
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the treatment of hyperlipemia with theophylline nicotinate].
    Ciammaichella A
    Atti Soc Ital Cardiol; 1969 Jan; 2():251-60. PubMed ID: 5406537
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of disorders of peripheral circulation with complamine by infusion with glucose].
    Miolin A; Radojcić B; Pekić B
    Med Arh; 1968; 22(3):65-70. PubMed ID: 5191769
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilator drugs and peripheral vascular disease.
    Drug Ther Bull; 1972 Nov; 10(23):91-2. PubMed ID: 4144248
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of cyclonicate in atherosclerotic coronary arteriopathy].
    Alvisi V; Strozzi C
    Minerva Cardioangiol; 1982 Apr; 30(4):209-11. PubMed ID: 7088305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative evaluation of the clinical effectiveness of spasmolytic preparations in coronary arteriosclerosis].
    Domanskaia MT
    Vrach Delo; 1973 Jul; 7(7):8-11. PubMed ID: 4756064
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of treatment of patients with coronary atherosclerosis with nicatol and nicotinic acid].
    Ivanchenko FT
    Vrach Delo; 1967 Jan; 1():76-80. PubMed ID: 4895148
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of Provasan].
    Wodniecki J; Wolański A
    Wiad Lek; 1970 Oct; 23(20):1791-3. PubMed ID: 5482235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of arteriosclerosis with nicatol].
    Zharko KP
    Vrach Delo; 1968 Sep; 9():49-52. PubMed ID: 5740305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.